Integrins as Therapeutic Targets for SARS-CoV-2

被引：7
|
作者：
Gressett, Timothy E. [1 ,2 ,3 ]
Nader, Danielle [4 ]
Robles, Juan Pablo [5 ]
Buranda, Tione [6 ]
Kerrigan, Steven W. [4 ]
Bix, Gregory [1 ,2 ,3 ]
机构：
[1] Tulane Univ, Clin Neurosci Res Ctr CNRC, Sch Med, New Orleans, LA USA
[2] Tulane Univ, Dept Neurol, Sch Med, New Orleans, LA USA
[3] Tulane Univ, Tulane Brain Inst, New Orleans, LA USA
[4] RCSI Univ Med & Hlth Sci, Sch Pharm & Biomol Sci PBS, Dublin, Ireland
[5] Univ Nacl Autonoma Mexico, Inst Neurobiol, Juriquilla, Mexico
[6] Univ New Mexico Hlth Sci Ctr HSC, Dept Pathol, Albuquerque, NM USA
来源：
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2022年 / 12卷
关键词：
integrins; SARS-CoV-2; therapeutic; RGD; ATN-161; cilengitide; PEPTIDE; ATN-161;
D O I：
10.3389/fcimb.2022.892323
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
下载
收藏
页数：5
相关论文
共 50 条
  • [1] Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2
    Chukwuma, Ifeoma Felicia
    Apeh, Victor Onukwube
    Chiletugo, Okwesili Fred
    ACTA VIROLOGICA, 2021, 65 (01) : 3 - 9
  • [2] SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
    Shivshankar, Pooja
    Karmouty-Quintana, Harry
    Mills, Tingting
    Doursout, Marie-Francoise
    Wang, Yanyu
    Czopik, Agnieszka K.
    Evans, Scott E.
    Eltzschig, Holger K.
    Yuan, Xiaoyi
    INFLAMMATION, 2022, 45 (04) : 1430 - 1449
  • [3] Potential therapeutic targets and promising drugs for combating SARS-CoV-2
    Zhou, Hong
    Fang, Yan
    Xu, Tao
    Ni, Wei-Jian
    Shen, Ai-Zong
    Meng, Xiao-Ming
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (14) : 3147 - 3161
  • [4] Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
    Ho, Gilbert
    Ali, Alysha
    Takamatsu, Yoshiki
    Wada, Ryoko
    Masliah, Eliezer
    Hashimoto, Makoto
    DRUG DISCOVERY TODAY, 2021, 26 (08) : 2036 - 2044
  • [5] SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
    Pooja Shivshankar
    Harry Karmouty-Quintana
    Tingting Mills
    Marie-Francoise Doursout
    Yanyu Wang
    Agnieszka K. Czopik
    Scott E. Evans
    Holger K. Eltzschig
    Xiaoyi Yuan
    Inflammation, 2022, 45 : 1430 - 1449
  • [6] Peptide Targets to SARS-CoV-2
    Mandal, Santi M.
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2020, 12 (04) : 234 - +
  • [7] Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets
    Khan, Muhammad Tahir
    Irfan, Muhammad
    Ahsan, Hina
    Ahmed, Abrar
    Kaushik, Aman Chandra
    Khan, Anwar Sheed
    Chinnasamy, Sathishkumar
    Ali, Arif
    Wei, Dong-Qing
    INTERVIROLOGY, 2021, 64 (02) : 55 - 68
  • [8] Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
    Policard, Martine
    Jain, Sidharth
    Rego, Samantha
    Dakshanamurthy, Sivanesan
    VIRUS RESEARCH, 2021, 301
  • [9] T Lymphocytes as Targets for SARS-CoV-2
    Elena M. Kuklina
    Biochemistry (Moscow), 2022, 87 : 566 - 576
  • [10] T Lymphocytes as Targets for SARS-CoV-2
    Kuklina, Elena M.
    BIOCHEMISTRY-MOSCOW, 2022, 87 (06) : 566 - 576
12345